News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Reata Pharma
(NQ:
RETA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Reata Pharma
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
12 Health Care Stocks Moving In Monday's Intraday Session
February 27, 2023
Via
Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 21, 2023
Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 21, 2023
Via
Benzinga
Looking Into Reata Pharmaceuticals's Return On Capital Employed
December 05, 2022
Via
Benzinga
Analyst Ratings for Reata Pharmaceuticals
November 28, 2022
Via
Benzinga
Why Reata Pharmaceuticals Stock Is Soaring Today
November 08, 2022
Investors are cheering the company's third-quarter update.
Via
The Motley Fool
The Nasdaq Is Rebounding: 2 Supercharged Growth Stocks to Buy in February
February 01, 2023
These two growth stocks might deliver enormous gains for shareholders this month.
Via
The Motley Fool
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
January 31, 2023
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new...
Via
Benzinga
Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands
November 28, 2022
Goldman Sachs boosted the price target on Reata Pharmaceuticals, Inc. (NASDAQ: RETA) from $86 to $115. Goldman Sachs analyst Madhu Kumar maintained the stock with a Buy rating. Reata Pharmaceuticals...
Via
Benzinga
Reata Pharmaceuticals Announces Participation in the Guggenheim 2022 Immunology and Neurology Conference and the Stifel 2022 Healthcare Conference
November 10, 2022
From
Reata Pharmaceuticals, Inc.
Via
Business Wire
Planet Fitness To Surge Over 25%? Plus Morgan Stanley Cuts PT On This Stock By 50%
November 09, 2022
Raymond James raised the price target on Planet Fitness, Inc. (NYSE: PLNT) from $70 to $84. Raymond James analyst Joseph Altobello maintained a Strong Buy rating on the stock. Planet Fitness shares...
Via
Benzinga
DuPont, Expeditors International, Planet Fitness And Other Big Gainers From Tuesday
November 09, 2022
U.S. stocks closed higher on Tuesday, with the Dow Jones surging more than 300 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Reata Pharmaceuticals, Inc. Announces Third Quarter 2022 Financial Results and Provides an Update on Clinical Development Programs
November 08, 2022
From
Reata Pharmaceuticals, Inc.
Via
Business Wire
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
November 09, 2022
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Via
Benzinga
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
November 08, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast...
Via
Benzinga
Reata Pharmaceuticals, Inc. to Report Third Quarter 2022 Financial Results and to Provide an Update on Clinical Development Programs on November 8, 2022
October 31, 2022
From
Reata Pharmaceuticals, Inc.
Via
Business Wire
2 On-Fire Biotech Stocks That Are Crushing the Bear Market
October 31, 2022
The biotech sector is down this year, but these two biopharmaceutical stocks have delivered strong returns.
Via
The Motley Fool
Reata Pharmaceuticals Announces Presentations at the International Congress for Ataxia Research 2022
October 20, 2022
From
Reata Pharmaceuticals, Inc.
Via
Business Wire
Dow Dips 375 Points; S&P 500 Down Over 2%
October 14, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 375 points on Friday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
October 19, 2022
Upgrades
Via
Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
October 18, 2022
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
Via
Benzinga
Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday
October 17, 2022
Gainers Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45. FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52.
Via
Benzinga
Why Is Reata Pharmaceuticals (RETA) Stock Up 15% Today?
October 14, 2022
The FDA will not hold a meeting to review Reata Pharmaceuticals’ therapeutic for a rare disorder yet RETA stock soared. Here’s why.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
October 14, 2022
Gainers
Via
Benzinga
Why Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday's Mid-Day Session
October 14, 2022
Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) surged 77.7% to $9.35.
Via
Benzinga
Nasdaq Tumbles Over 200 Points; Crude Oil Falls Sharply
October 14, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Friday.
Via
Benzinga
US Stocks Open Lower; Dow Drops Over 100 Points
October 14, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Friday.
Via
Benzinga
Reata Pharmaceuticals Announces that the FDA Does Not Plan to Hold an Advisory Committee Meeting to Discuss the NDA for Omaveloxolone for Friedreich’s Ataxia
October 13, 2022
From
Reata Pharmaceuticals, Inc.
Via
Business Wire
Reata Pharmaceuticals Announces Participation in the Citi 17th Annual BioPharma Conference
September 06, 2022
From
Reata Pharmaceuticals, Inc.
Via
Business Wire
Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday
September 08, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.